Clinical Trial Update: ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 trial update of ACT01 in combination with Comp01-04 for actinic keratosis was completed with results posted on 2016-02-22.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• ACT01
• Comp01-04

Snippet

Sponsor: Promius Pharma, LLC | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED | Results posted: 2016-02-22